Molecular Signature Expands the Landscape of Driver Negative Thyroid Cancers
Thyroid cancer is the most common endocrine malignancy. However, the cytological diagnosis of follicular thyroid carcinoma (FTC), Hürthle cell carcinoma (HCC), and follicular variant of papillary thyroid carcinoma (FVPTC) and their benign counterparts is a challenge for preoperative diagnosis. Nearl...
Main Authors: | Larissa Valdemarin Bim, Thaise Nayane Ribeiro Carneiro, Vanessa Candiotti Buzatto, Gabriel Avelar Colozza-Gama, Fernanda C. Koyama, Debora Mota Dias Thomaz, Ana Carolina de Jesus Paniza, Eunjung Alice Lee, Pedro Alexandre Favoretto Galante, Janete Maria Cerutti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/20/5184 |
Similar Items
-
Diffuse follicular variant of papillary thyroid carcinoma: a case report with a revision of literature
by: Gian Luca Rampioni Vinciguerra, et al.
Published: (2016-12-01) -
Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
by: Aleksandra Bożyk, et al.
Published: (2021-03-01) -
Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma
by: Rossella Puglisi, et al.
Published: (2021-06-01) -
The combination of mutations in BRAF and NRAS genes within a one tumor in patients with cutaneous melanoma
by: M. B. Aksenenko, et al.
Published: (2019-10-01) -
miR-146a promotes the initiation and progression of melanoma by activating Notch signaling
by: Matteo Forloni, et al.
Published: (2014-02-01)